For the Inventor, By the Inventor

Enter assignee name

Perseus Proteomics Inc.

USPTO Granted Patents = 26

% Expired Patents = 53.8

CIPO Patents = 2

EPO Patents = 16

Forward Citations = 63

Loading Chart...

Loading Chart...

70 inventors (with patents filed for the assignee):

Hiroyuki Aburatani (12 out of 27 patents)

Katsuyuki Mitomo (8 out of 9 patents)

Hiroko Iwanari (8 out of 10 patents)

4. Katsushi Kouda (7 out of 7 patents)

5. Yukio Ito (6 out of 87 patents)

6. Takao Hamakubo (6 out of 17 patents)

7. Keisuke Ishii (5 out of 28 patents)

8. Yoko Kayukawa (5 out of 5 patents)

9. Fumiko Nomura (5 out of 5 patents)

10. Yoshitaka Hippo (5 out of 6 patents)

11. Lilin Zhang (5 out of 5 patents)

12. Tatsuhiko Kodama (4 out of 31 patents)

13. Hirotaka Ito (4 out of 25 patents)

14. Gene Kurosawa (4 out of 7 patents)

15. Yoshikazu Kurosawa (4 out of 13 patents)

26 patents: Sort by Forward Citations

1. 11951168 - Composition containing buffer (2024-04-09),

2. 10030071 - Antibody which specifically reacts with human integrin A6B4 (2018-07-24),

3. 9764041 - Drug conjugate comprising anti-CDH3 (P-cadherin) antibody (2017-09-19),

4. 9644029 - Cancer diagnosis and treatment of cancer using anti-ROBO1 antibody (2017-05-09),

5. 9644028 - Anti-CDH3 humanized antibody, drug conjugate thereof, and use thereof (2017-05-09),

6. 9598496 - Antibody capable of specifically recognizing transferrin receptor (2017-03-21),

7. 9593165 - Antibody capable of specifically recognizing transferrin receptor (2017-03-14),

8. 9513292 - Method for diagnosing cancer by detecting GPC3 (2016-12-06),

9. 9434775 - Gene overexpressed in cancer (2016-09-06),

10. 9376475 - Gene overexpressed in cancer (2016-06-28),

11. 9328160 - Anti-CDH3 antibody having high internalization capacity (2016-05-03),

12. 9273140 - Antibody for detecting DNA damage in cells utilizing cell membrane surface antigen Ly6D (2016-03-01),

13. 9155805 - Monoclonal antibody, and use thereof (2015-10-13),

14. 9127061 - Anti-human P-cadherin (CDH3) recombinant antibody (2015-09-08),

15. 9017683 - Highly effective anti-cadherin antibody for induction of antibody-dependent cellular cytotoxicity in vivo (2015-04-28),

Perseus Proteomics Inc. is a biotechnology company that specializes in proteomics research and development. They provide innovative solutions and technologies for the identification, characterization, and quantification of proteins. With a team of experienced scientists, Perseus Proteomics continues to push the boundaries of proteomics, enabling advancements in various fields including personalized medicine, drug discovery, and biomarker identification. Visit their website to learn more about their cutting-edge solutions.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Sep 15 2026

26 Patents

#1,160 in Tokyo

#2,500 in Japan

#24,724 in the World

Perseus Proteomics Inc.

Forward Citations = 63

70 inventors:

Hiroyuki Aburatani (12 out of 27 patents)

Katsuyuki Mitomo (8 out of 9 patents)

Hiroko Iwanari (8 out of 10 patents)

4. Katsushi Kouda (7 out of 7 patents)

5. Yukio Ito (6 out of 87 patents)

Please report any incorrect information to [email protected]

Loading…